Recruiting
Cardiac failure acute
RecruitingStudy on the Safety and Effectiveness of Engineered Human Myocardium for Patients with Terminal Heart Failure
InvestigationalNo placebo
Study on the Safety and Effectiveness of Engineered Human Myocardium for Patients with Terminal Heart Failure
InvestigationalNo placebo
- Disease:Cardiac failure acute
- Substances:Allogeneic Induced Pluripotent Stem Cells-Derived Cardiomyocytes And Stromal Cells
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Allogeneic Induced Pluripotent Stem Cells-Derived Cardiomyocytes And Stromal Cells
